Enzyme replacement therapy in two patients with an advanced severe (Hurler) phenotype of mucopolysaccharidosis I

By Tokic Visnja   Barisic Ingeborg   Huzjak Nevenka   Petkovic Giorgie   Fumic Ksenija   Paschke Eduard  

European Journal of Pediatrics, Vol. 166, Iss. 7, 2007-07 ,pp. : 727-732

Springer Publishing Company

Access to resources Recommend Favorite

Successful pregnancy outcome in a patient with Fabry disease receiving enzyme replacement therapy with agalsidase alfa

By Wendt S.   Whybra C.   Kampmann C.   Teichmann E.   Beck M.  

Journal of Inherited Metabolic Disease, Vol. 28, Iss. 5, 2005-09 ,pp. : 787-788

Springer Publishing Company

Access to resources Recommend Favorite

Massive Accumulation of Glycosaminoglycans in the Aortic Valve of a Patient With Hunter Syndrome During Enzyme Replacement Therapy

By Sato Yohei   Fujiwara Masako   Kobayashi Hiroshi   Ida Hiroyuki  

Pediatric Cardiology, Vol. 34, Iss. 8, 2013-12 ,pp. : 2077-2079

Springer Publishing Company

Access to resources Recommend Favorite

Postmortem studies on a patient with mucopolysaccharidosis type I: Histopathological findings after one year of enzyme replacement therapy

By Yano S.   Moseley K.   Pavlova Z.  

Journal of Inherited Metabolic Disease, Vol. 32, Iss. 1, 2009-12 ,pp. : 53-57

Springer Publishing Company

Access to resources Recommend Favorite

Enzyme replacement therapy in Fabry disease

By Brady R.   Murray G.   Moore D.   Schiffmann R.  

Journal of Inherited Metabolic Disease, Vol. 24, Iss. 2, 2001-04 ,pp. : 18-24

Springer Publishing Company

Access to resources Recommend Favorite